Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification

By Puyaan Singh and Christy Santhosh April 30 (Reuters) – Companies developing cannabis-based medicines say U.S. moves to loosen restrictions on the drug could unlock private funding and the public …